235 related articles for article (PubMed ID: 27433859)
1. Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative.
Drieling RL; LaCroix AZ; Beresford SA; Boudreau DM; Kooperberg C; Chlebowski RT; Gass M; Crandall CJ; Womack CR; Heckbert SR
Menopause; 2016 Nov; 23(11):1168-1175. PubMed ID: 27433859
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health Initiative.
Drieling RL; LaCroix AZ; Beresford SAA; Boudreau DM; Kooperberg C; Chlebowski RT; Ko MG; Heckbert SR
J Am Geriatr Soc; 2017 Sep; 65(9):1924-1931. PubMed ID: 28555811
[TBL] [Abstract][Full Text] [Related]
3. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
Wang CC; Lu HT; Dusetzina SB; Wu CH
J Womens Health (Larchmt); 2016 Jul; 25(7):738-46. PubMed ID: 27096405
[TBL] [Abstract][Full Text] [Related]
4. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.
Chen Z; Maricic M; Bassford TL; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS
Arch Intern Med; 2005 Mar; 165(5):552-8. PubMed ID: 15767532
[TBL] [Abstract][Full Text] [Related]
5. Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative.
Passarelli MN; Newcomb PA; LaCroix AZ; Lane DS; Ho GY; Chlebowski RT
J Bone Miner Res; 2013 Sep; 28(9):2043-8. PubMed ID: 23519920
[TBL] [Abstract][Full Text] [Related]
6. Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials.
Sullivan SD; Lehman A; Nathan NK; Thomson CA; Howard BV
Menopause; 2017 Apr; 24(4):371-378. PubMed ID: 27801706
[TBL] [Abstract][Full Text] [Related]
7. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
Black DM; Geiger EJ; Eastell R; Vittinghoff E; Li BH; Ryan DS; Dell RM; Adams AL
N Engl J Med; 2020 Aug; 383(8):743-753. PubMed ID: 32813950
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
Ito K; Blinder VS; Elkin EB
J Clin Oncol; 2012 May; 30(13):1468-75. PubMed ID: 22370313
[TBL] [Abstract][Full Text] [Related]
9. Oral bisphosphonate use and lung cancer incidence among postmenopausal women.
Tao MH; Chen S; Freudenheim JL; Cauley JA; Johnson KC; Mai X; Sarto GE; Wakelee H; Boffetta P; Wactawski-Wende J
Ann Oncol; 2018 Jun; 29(6):1476-1485. PubMed ID: 29617712
[TBL] [Abstract][Full Text] [Related]
10. Risk of Subsequent Fractures in Postmenopausal Women After Nontraumatic vs Traumatic Fractures.
Crandall CJ; Larson JC; LaCroix AZ; Robbins JA; Wactawski-Wende J; Johnson KC; Sattari M; Stone KL; Weitlauf JC; Gure TR; Cauley JA
JAMA Intern Med; 2021 Aug; 181(8):1055-1063. PubMed ID: 34096979
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
Earnshaw SR; Graham CN; Ettinger B; Amonkar MM; Lynch NO; Middelhoven H
Curr Med Res Opin; 2007 Oct; 23(10):2517-29. PubMed ID: 17825128
[TBL] [Abstract][Full Text] [Related]
12. Oral bisphosphonate use and breast cancer incidence in postmenopausal women.
Chlebowski RT; Chen Z; Cauley JA; Anderson G; Rodabough RJ; McTiernan A; Lane DS; Manson JE; Snetselaar L; Yasmeen S; O'Sullivan MJ; Safford M; Hendrix SL; Wallace RB
J Clin Oncol; 2010 Aug; 28(22):3582-90. PubMed ID: 20567009
[TBL] [Abstract][Full Text] [Related]
13. Adherence to bisphosphonate treatment by elderly women.
Berecki-Gisolf J; Hockey R; Dobson A
Menopause; 2008; 15(5):984-90. PubMed ID: 18520695
[TBL] [Abstract][Full Text] [Related]
14. Estimating bisphosphonate use and fracture reduction among US women aged 45 years and older, 2001-2008.
Siris ES; Pasquale MK; Wang Y; Watts NB
J Bone Miner Res; 2011 Jan; 26(1):3-11. PubMed ID: 20662073
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a) plasma levels, bone mineral density and risk of hip fracture: a post hoc analysis of the Women's Health Initiative, USA.
Haring B; Crandall CJ; Carbone L; Liu S; Li W; Johnson KC; Wactawski-Wende J; Shadyab AH; Gass ML; Kamensky V; Cauley JA; Wassertheil-Smoller S
BMJ Open; 2019 Apr; 9(4):e027257. PubMed ID: 31023762
[TBL] [Abstract][Full Text] [Related]
16. Oral bisphosphonate use and risk of postmenopausal endometrial cancer.
Newcomb PA; Passarelli MN; Phipps AI; Anderson GL; Wactawski-Wende J; Ho GY; O'Sullivan MJ; Chlebowski RT
J Clin Oncol; 2015 Apr; 33(10):1186-90. PubMed ID: 25713431
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates and other bone agents for breast cancer.
O'Carrigan B; Wong MH; Willson ML; Stockler MR; Pavlakis N; Goodwin A
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003474. PubMed ID: 29082518
[TBL] [Abstract][Full Text] [Related]
18. Effects of bisphosphonates on fracture incidence and bone metabolism in rheumatoid arthritis patients in general practice taking long-term corticosteroid therapy: a retrospective study.
Katayama K; Matsuno T
Clin Drug Investig; 2008; 28(3):149-58. PubMed ID: 18266400
[TBL] [Abstract][Full Text] [Related]
19. Association of pelvic organ prolapse and fractures in postmenopausal women: analysis of baseline data from the Women's Health Initiative Estrogen Plus Progestin trial.
Pal L; Hailpern SM; Santoro NF; Freeman R; Barad D; Kipersztok S; Barnabei VM; Wassertheil-Smoller S
Menopause; 2008; 15(1):59-66. PubMed ID: 18257143
[TBL] [Abstract][Full Text] [Related]
20. Osteoporosis treatment and 10 years' oestrogen receptor+ breast cancer outcome in postmenopausal women treated with aromatase inhibitors.
Bouvard B; Chatelais J; Soulié P; Hoppé E; Saulnier P; Capitain O; Mege M; Mesgouez-Nebout N; Jadaud E; Abadie-Lacourtoisie S; Campone M; Legrand E
Eur J Cancer; 2018 Sep; 101():87-94. PubMed ID: 30036740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
